Edwards Michael R, Strong Katherine, Cameron Aoife, Walton Ross P, Jackson David J, Johnston Sebastian L
COPD & Asthma Section, National Heart Lung Institute, Imperial College London, London, United Kingdom; MRC & Asthma UK Centre for Allergic Mechanisms of Asthma, London, United Kingdom.
COPD & Asthma Section, National Heart Lung Institute, Imperial College London, London, United Kingdom; MRC & Asthma UK Centre for Allergic Mechanisms of Asthma, London, United Kingdom.
J Allergy Clin Immunol. 2017 Oct;140(4):909-920. doi: 10.1016/j.jaci.2017.07.025.
Viral respiratory tract infections are associated with asthma inception in early life and asthma exacerbations in older children and adults. Although how viruses influence asthma inception is poorly understood, much research has focused on the host response to respiratory viruses and how viruses can promote; or how the host response is affected by subsequent allergen sensitization and exposure. This review focuses on the innate interferon-mediated host response to respiratory viruses and discusses and summarizes the available evidence that this response is impaired or suboptimal. In addition, the ability of respiratory viruses to act in a synergistic or additive manner with T2 pathways will be discussed. In this review we argue that these 2 outcomes are likely linked and discuss the available evidence that shows reciprocal negative regulation between innate interferons and T2 mediators. With the renewed interest in anti-T2 biologics, we propose a rationale for why they are particularly successful in controlling asthma exacerbations and suggest ways in which future clinical studies could be used to find direct evidence for this hypothesis.
病毒性呼吸道感染与儿童早期哮喘的发病以及大龄儿童和成人哮喘的加重有关。尽管目前对病毒如何影响哮喘发病知之甚少,但许多研究都集中在宿主对呼吸道病毒的反应以及病毒如何促进;或者宿主反应如何受到随后的过敏原致敏和暴露的影响。本综述重点关注先天性干扰素介导的宿主对呼吸道病毒的反应,并讨论和总结现有证据表明这种反应受损或未达最佳状态。此外,还将讨论呼吸道病毒与2型途径协同或累加作用的能力。在本综述中,我们认为这两种结果可能存在关联,并讨论现有证据表明先天性干扰素与2型介质之间存在相互负调控。随着人们对抗2型生物制剂重新产生兴趣,我们提出了一个理由,解释为什么它们在控制哮喘加重方面特别成功,并提出未来临床研究可用于寻找这一假设直接证据的方法。